NanoPhoria receives a 3.5M€ seed grant from Sofinnova Partners a leading European life sciences venture capital firm based in Paris, London and Milan Posted on 22 May 202210 February 2026 by Ed Gover
NanoPhoria has been granted an exclusive patent licence for a drug delivery platform based on inorganic nanoparticles. This acquisition will aid in the launch new products capable of optimizing the results of therapies and reducing side effects for patients Posted on 16 May 202210 February 2026 by Ed Gover
